Skip to main navigation
Skip to content
  • Careers
  • Contact
Pyxis Oncology Logo
  • About
    • Overview
    • Leadership
    • Partners
  • Analyst Coverage
  • Our Approach
    • ADC Landscape
    • I/O Landscape
  • Portfolio
    • A NOVEL PIPELINE
    • ADCS
    • OUR TARGET CATALOG
  • Investors
    • News Releases
    • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • RSS Feeds
      • Proxy and Annual Meeting
  • Media Coverage
Pyxis Oncology Logo
  • About
    • Overview
    • Leadership
    • Partners
  • Analyst Coverage
  • Our Approach
    • ADC Landscape
    • I/O Landscape
  • Portfolio
    • A NOVEL PIPELINE
    • ADCS
    • OUR TARGET CATALOG
  • Investors
    • News Releases
    • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • RSS Feeds
      • Proxy and Annual Meeting
  • Media Coverage
  • Careers
  • Contact

News releases

May 13, 2022
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
PDF Version
Apr 27, 2022
Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference
PDF Version
Apr 13, 2022
Pyxis Oncology Announces Leadership Changes
PDF Version
Apr 08, 2022
Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting
PDF Version
Mar 29, 2022
Pyxis Oncology Provides Corporate and Financial Update
PDF Version
Mar 22, 2022
Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022
PDF Version

35 Cambridgepark Drive
Suite 100-R
Cambridge, MA 02140
(617) 453-3596 | info@pyxisoncology.com

Pyxis Oncology
Twitter > Linkedin-in >
Copyright © 2022 Pyxis Oncology   
|   Privacy Policy